title: [Evaluation of safety and immunogenicity of the Td vaccine in laboratory studies].
abstract: The new vaccine recommended as the booster dose contains in 0.5 ml: 10 BU Te-toxoid, 2 Lf Di-toxoid, 4.5-0.5 mg Al and 0.01% merthiolate. In 7 consecutive series it was state, the vaccine was safety and stable. The potency was 40-50 JO for Te and 30-40 for Di. The last series was recommended for vaccination under clinical control.
authors.affiliation: Zakład Badania Surowic i Szczepionek Państwowego Zakładu Higieny, Warszawie.
authors.forename: D
authors.initials: D
authors.lastname: Rymkiewicz
authors.forename: J
authors.initials: J
authors.lastname: Sawicki
authors.forename: T
authors.initials: T
authors.lastname: Wysokińska
mesh_terms: D004168:Diphtheria Toxoid / Q000008:administration & dosage*; D006801:Humans; D013745:Tetanus Toxoid / Q000008:administration & dosage*
chemical_list: D004168:Diphtheria Toxoid; D013745:Tetanus Toxoid
vernacular_title: Ocena bezpieczeństwa i immunogenności szczepionki Td w badaniach laboratoryjnych.